Skip to Content

Publications

  • Kim ES, Hong WK, Lee JJ, Mao L, Morice RC, Liu DD, Jimenez CA, Eapen GA, Lotan R, Tang X, Newman RA, Wistuba II, Kurie JM. Biological activity of celecoxib in the bronchial epithelium of current and former smokers. Cancer Pres Res (Phila). 2010 Feb; 3(2):148-59. Epub 2010 Jan 26. PMID: 20103722 [PubMed-indexed for MEDLINE]

  • Roybal JD, Zang Y, Ahn YH, Yang Y, Gibbons DL, Baird BN, Alvarez C, Thilaganathan N, Liu DD, Saintigny P, Heymach JV, Creighton CJ, Kurie JM. miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1. Mol Cancer Res. 2011 Jan;9(1)25-35. Epub 2010 Nov 29. PMID: 21115742 [PubMed-indexed for MEDLINE]

  • Yang Y, Ahn YH, Gibbons DL, Zang Y, Lin W, Thilaganathan N, Alvarez CA, Moreira DC, Creighton CJ, Gregory PA, Goodall GJ, Kurie JM. The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200-dependent pathway in mice. J Clin Invest. 2011 Apr 1; 121(4):1373-85. Epub 2011 Mar 14. PMID: 21403400 [PubMed-indexed for MEDLINE]

  • Dragnev KH, Ma T, Cyrus J, Galimberti F, Memoli V, Busch AM, Tsongalis GJ, Seltzer M, Johnstone D, Erkmen CP, Nugent W, Rigas JR, Liu X, Freemantle SJ, Kurie JM, Waxman S, Dmitrovsky E. Bexarotene plus erlotinib suppress lung carcinogenesis independent of KRAS mutations in two clinical trials and transgenic models.  Cancer Prev Res (Phila). 2011 Jun;4(6):818-28. PMID: 21636548 [PubMed-indexed for MEDLINE]

  • Schliekelman MJ, Gibbons DL, Faca VM, Creighton CJ, Rizvi ZH, Zhang Q, Wong CH, Wang H, Ungewiss C, Ahn YH, Shin DH, Kurie JM, Hanash SM. Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer. Cancer Res. Epub 2011 Oct 10. PMID: 21987723 [PubMed-as supplied by publisher]

  • Ahn YH, Yang Y, Gibbons DL, Creighton CJ, Yang F, Wistuba II, Lin W, Thilaganathan N, Alvarez CA, Roybal J, Goldsmith EJ, Tournier C, Kurie JM. Map2k4 functions as a tumor suppressor in lung adenocarcinoma and inhibits tumor cell invasion by decreasing peroxisome proliferator-activated receptor γ2 expression. Mol Cell Biol, 31(21):4270-85. Epub 2011 Sep 6. PMID: 21896780 [PubMed-in process]

  • Sueoka N, Lee H-Y, Walsh GL, Fang B, Ji L, Roth JA, LaPushin R, Hong WK, Cohen P, Kurie JM. Insulin-like growth factor binding protein-6 inhibits the growth of human bronchial epithelial cells and increases in abundance with all-trans retinoic acid treatment. Am J Respir Cell Mol Biol, 23(3):297-303, 2000. (Article) (pdf - 7 pages)

  • Sueoka N, Lee H-Y, Wiehle S, Cristiano RJ, Fang B, Ji L, Roth JA, Hong WK, Cohen P, Kurie JM. Insulin-like growth factor binding protein-6 activates programmed cell death in non-small cell lung cancer cells. Oncogene, 19(38):4432-6, 2000. (Article) (pdf - 5 pages)

  • Lee HY, Suh YA, Robinson MJ, Clifford JL, Hong WK, Woodgett JR, Cobb MH, Mangelsdorf DJ, Kurie JM. Stress pathway activation induces phosphorylation of retinoid X receptor. J Biol Chem, 275(41):32193-32199, 2000. (Article) (pdf - 7 pages)

  • Suh YA, Lee HY, Virmani A, Wong J, Mann KK, Miller WH, Gazdar A, and Kurie JM. Loss of retinoic acid receptor b gene expression is linked to aberrant histone H3 acetylation in lung cancer cell lines. Cancer Res, 2: 3945-3949, 2002. (Article)

  • Lee HY, Suh YA, Lee JI, Hassan KA, Mao, Li, Force T, Gilbert BE, Jacks T, and Kurie JM. Inhibition of oncogenic k-ras signaling by aerosolized gene delivery in a mouse model of human lung cancer. Clin Cancer Res, 8:2907-2975, 2002. (Article)

  • Lee HY, Chun K-H, Liu B, Wiehle SA, Cristiano, RJ, Hong WK, Cohen P, and Kurie JM. Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer. Cancer Res, 62:3530-3537, 2002. (Article)

  • Lee H-Y, Srinivas H, Xia D, Lu Y, Superty R, LaPushin R, Gomez-Manzano C, Gal AM, Walsh GL, Force T, Ueki K, Mills GB, Kurie JM. Evidence that phosphatidylinositol 3-kinase-and mitogen-activated protein kinase kinase-4/c-Jun NH2-terminal kinase–dependent pathways cooperate to maintain lung cancer cell survival. J Biol Chem, 278:23630-23638, 2003. (Article) (pdf - 9 pages)

  • Tsao AS, Mcdonnell T, Lam S, Putnam JB, Bekele N, Hong WK, Kurie JM. Increased phospho-AKT (Ser473) expression in bronchial dysplasia: implications for lung cancer prevention studies. Cancer Epidemiol Biomarkers Prev, 12:660-664, 2003. (Article)

  • Cavanaugh D, Johnson E, Price RE, Kurie J, Travis EL, Cody DD. In vivo respiratory-gated micro-CT imaging in small-animal oncology models. Mol Imaging, 3(1)55-62, 2004. (Article) (pdf - 8 pages)

  • Srinivas H, Juroske DM, Kalyankrishna S, Cody DD, Price RE, Xu XC, Narayanan R, Weigel NL, Kurie JM. cJun N-terminal kinase contributes to aberrant retinoid signaling in lung cancer cells by phosphorylating and inducing proteasomal degradation of retinoic acid receptor-a. Mol Cell Biol, 25:1054-1069, 2005. (Article) (pdf - 16 pages)

  • Amann J, Kalyankrishna S, Massion PP, Ohm JE, Girard L, Shigematsu H, Peyton M, Juroske D, Huang Y, Salmon JS, Kim YH, Pollack JR, Yanagisawa K, Gazdar A, Minna JD, Kurie JM, Carbone DP. Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitor in lung cancer. Cancer Res, 65:226-235, 2005. (Article)

  • Wislez M, Spencer ML, Izzo JG, Juroske DM, Balhara K, Cody DD, Price RE, Hittelman WN, Wistuba II, Kurie JM. Inhibition of mammalian target of rapamycin reverses alveolar epithelial neoplasia induced by oncogenic K-ras. Cancer Res, 65:3226-35, 2005. (Article)

  • Fujimoto N, Wislez M, Zhang J, Iwanaga K, Dackor J, Hanna AE, Kalyankrishna S, Cody DD, Price RE, Sato M, Shay JW, Minna JD, Peyton M, Tang X, Massarelli E, Herbst R, Threadgill DW, Wistuba II, Kurie JM. High expression of ErbB family members and their ligands in lung adenocarcinomas that are sensitive to inhibition of epidermal growth factor receptor. Cancer Res, 65(24):11478-85, 2005.

  • Srinivas H, Xia D, Moore NL, Uray IP, Kim H, Ma L, Weigel NL, Brown PH, Kurie JM. Akt phosphorylates and suppresses the transactivation of retinoic acid receptor alpha. Biochem J, 395(3):653-62, 2006.

  • Wislez M, Fujimoto N, Izzo JG, Hanna AE, Cody DD, Langley RR, Tang H, Burdick MD, Sato M, Minna JD, Mao L, Wistuba I, Streiter RM, Kurie JM. High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras. Cancer Res, 66(8):4198-207, 2006.

  • Khatlani TS, Wislez M, Sun M, Srinivas H, Iwanaga K, Ma L, Hanna AE, Lui D, Girard L, Kim YH, Pollack JR, Minna JD, Wistuaba II, Kurie JM. c-Jun N-terminal kinase is activated in non-small-cell lung cancer and promotes neoplastic transformation in human bronchial epithelial cells. Oncogene, 26(18):2658-66, 2007.

  • Xia D, Srinivas H, Ahn YH, Sethi G, Sheng X, Yung WK, Xia Q, Chiao PJ, Kim H, Brown PH, Wistuba II, Aggarwal BB, Kurie JM. Mitogen-activated protein kinase kinase-4 promotes cell survival by decreasing PTEN expression through an NF kappa B-dependent pathway. J Biol Chem, 282(6):3507-19, 2007.

  • Zhang J, Kalyankrishna S, Wislez M, Thilaganathan N, Saigal B, Wei W, Ma L, Wistuaba II, Johnson FM, Kurie JM. SRC-family kinases are activated in non-small cell lung cancer and promote the survival of epidermal growth factor receptor-dependent cell lines. Am J Pathol, 170(1):366-76, 2007.

  • Choi K, Creighton CJ, Stivers D, Fujimoto N, Kurie JM. Transcriptional profiling of non-small cell lUng cancer cells with activating EGFR somatic mutations. PLoS ONE, 2(11):e1226, 2007.

  • Zhang J, Kalyankrishna S, Wislez M, Thilaganathan N, Saigal B, Wei W, Ma L, Wistuba I, Johnson F, Kurie JM. Src-family kinases are activated in non-small cell lung cancer and promote the survival of EGFR-dependent cell lines. Am. J. Pathol. 170(1):366-367, 2007.

  • Sethi G, Ahn KS, Xia D, Kurie JM, and Aggarwal BB. Targeted Deletion of MKK4 Gene Potentiates TNF-Induced Apoptosis through the Down-Regulation of NF-kB Activation and NF-kB-Regulated Antiapoptotic Gene Products1. J. Immunol 179:1926-1933, 2007.

  • Yang Y, Wislez M, Fujimoto N, Prudkin L, Izzo JG, Uno F, Ji L, Hanna AE, Langley RR, Liu D, Johnson FM, Wistuba II, Kurie JM. A selective small molecule inhibitor of c-Met, PHA-665752, reverses lung premalignancy induced by mutant K-ras. Mol Cancer Ther 7:952-60, 4/2008.

  • Iwanaga K, Yang Y, Raso MG, Ma L, Hanna AE, Thilaganathan N, Moghaddam S, Evans CM, Li H, Cai W, Sato M, Minna JD, Wu H, Creighton CJ, Demayo FJ, Wistuba II, Kurie JM. Pten Inactivation Accelerates Oncogenic K-ras-initiated Tumorigenesis in a Mouse Model of Lung Cancer. Cancer Research 68:1119-27, 2008.

  • Zhang J, Iwanaga K, Choi KC, Wislez M, Raso MG, Wei W, Wistuba II, Kurie JM. Intratumoral Epiregulin Is a Marker of Advanced Disease in Non-Small Cell Lung Cancer Patients and Confers Invasive Properties on EGFR-Mutant Cells. Cancer Prev Res. In Press. e-Pub 3/2008.

  • Yang Y, Iwanaga I, Raso MG, Wislez M, Hanna AE, Wieder ED, Molldrem JJ, Wistuba II, Powis G, Demayo FJ, Bender-Kim CF, Kurie JM. Phosphatidylinositol 3-Kinase Mediates Bronchioalveolar Stem Cell Expansion in Mouse Models of Oncogenic K-ras-induced Lung Cancer. PLoS One. e2220 May 21, 2008.

  • Zhong L, Roybal JD, Chaerkady R, Zhang W, Choi K, Alvarez CA, Tran H, Creighton CJ, Yan S, Strieter RM, Pandey A, Kurie JM Identification of Secreted Proteins that Mediate Cell-Cell Interactions in an In Vitro Model of the Lung Cancer Microenvironment. Cancer Res, in press, 2008.

  • Zhang J, Iwanaga K, Choi KC, Wislez M, Raso MG, Wei W, Wistuba II, Kurie JM. Intratumoral epiregulin is a marker of advanced disease in non-small cell lung cancer patients and confers invasive properties on EGFR-mutant cells. Cancer Prev Res (Phila Pa). 2008 Aug;1(3):201-7. Epub 2008 Mar 31.PMID: 19138957 [PubMed - indexed for MEDLINE]

  • Sun H, Chung WC, Ryu SH, Ju Z, Tran HT, Kim E, Kurie JM, Koo JS. Cyclic AMP-responsive element binding protein- and nuclear factor-kappaB-regulated CXC chemokine gene expression in lung carcinogenesis. Cancer Prev Res (Phila Pa). 2008 Oct;1(5):316-28.PMID: 19138976 [PubMed - indexed for MEDLINE]

  • Moghaddam SJ, Li H, Cho SN, Dishop MK, Wistuba II, Ji L, Kurie JM, Dickey BF, Demayo FJ. Promotion of lung carcinogenesis by chronic obstructive pulmonary disease-like airway inflammation in a K-ras-induced mouse model. Am J Respir Cell Mol Biol. 2009 Apr;40(4):443-53. Epub 2008 Oct 16.PMID: 18927348 [PubMed - indexed for MEDLINE]

  • Choi K, Ahn YH, Gibbons DL, Tran HT, Creighton CJ, Girard L, Minna JD, Qin FX, Kurie JM. Distinct biological roles for the notch ligands Jagged-1 and Jagged-2. J Biol Chem. 2009 Jun 26;284(26):17766-74. Epub 2009 Apr 27.PMID: 19398556 [PubMed - indexed for MEDLINE]

  • Gibbons DL, Lin W, Creighton CJ, Zheng S, Berel D, Yang Y, Raso MG, Liu DD, Wistuba II, Lozano G, Kurie JM.Expression signatures of metastatic capacity in a genetic mouse model of lung adenocarcinoma.PLoS One. 2009;4(4):e5401. Epub 2009 Apr 30.PMID: 19404390 [PubMed - indexed for MEDLINE]

  • Lee D, Yu M, Lee E, Kim H, Pannicia C, Kurie JM, Threadgill DW. Tumor-specific apoptosis caused by deletion of the ERBB3 pseudo-kinase in mouse intestinal epithelium. J Clin Invest. 2009 Sep; 119(9): 2702-13. doi:10.1172/JCI36435. Epub 2009 Aug 17. PMID:1960388 [PubMed-indexed for MEDLINE]

  • Gibbons DL, Lin W, Creighton CJ, Rizvi ZH, Gregory PA, Goodall GJ, Thilaganathan N, Du L, Zhang Y, Pertsemlidis A, Kurie JM. Contextual extracellular cues promote tumor cell EMT and metastasis by regulating mir-200 family expression. Genes Dev. 2009 Sep 15;23(18):2140-51. PMID:19759262 [PubMed-indexed for MEDLINE]

  • Ahn YH, Kurie JM. MKK4/SEK1 is negatively regulated through a feedback loop involving the E3 ubiquitin ligase itch. J Biol Chem. 2009 Oct 23;284(43):29399-404. Epub 2009 Sep 8. PMID:19737936 [PubMed-indexed for MEDLINE]

Related Department

Related Program


© 2013 The University of Texas MD Anderson Cancer Center